DHA+ARA Supplementation For Adolescents And Older Adults: Is The Combined Formulation Necessary?

When it comes to the "golden duo" of DHA and ARA, most people associate them exclusively with infant formula. Both consumers and procurement professionals frequently raise questions: are DHA+ARA only required for young infants? During adolescence, a period of rapid brain development, and older adulthood when cognitive function needs preservation, should people take DHA-only supplements or opt for combined DHA+ARA formulations instead? How should different population groups choose, and are there any contraindications? This article offers purchasing guidance for general consumers and practical insights for purchasers on product formulation and market science communication. Drawing on dietary standards and scientific evidence, it objectively analyses applicable scenarios, benefits and limitations of DHA+ARA supplementation for adolescents and older adults.

First, a key concept needs clarification: ARA (arachidonic acid) is a conditionally essential fatty acid. Infants have low activity of endogenous conversion enzymes and must obtain ARA from external dietary sources. Adolescents, adults and older adults can theoretically synthesise ARA from linoleic acid obtained from food. Nevertheless, synthesis efficiency varies with age, dietary patterns and metabolic status, and sufficient endogenous production cannot be guaranteed for everyone. Found in high concentrations within brain grey matter, ARA remains vital across the entire human lifespan and is by no means an infant-specific nutrient. It should be noted that China's current Dietary Reference Intakes for Chinese Residents sets explicit intake recommendations for DHA/EPA but no standalone supplemental dosage for ARA among the general population. This regulatory gap partly contributes to confusion over product selection in the marketplace.

Let us first examine adolescents. Ages 13-18 mark the second critical window for brain development. Prefrontal myelination and hippocampal memory systems continue to mature. Burdened by heavy academic workloads, adolescent brains undergo intensive neural synaptic remodelling, generating high consumption of long-chain polyunsaturated fatty acids. Domestic survey data show widespread DHA insufficiency among Chinese adolescents, while the physiological role of ARA is frequently overlooked.

Adolescents with well-balanced diets who regularly consume eggs, meat and animal offal obtain adequate ARA precursors from food, and endogenous synthesis generally meets physiological requirements. Under such circumstances, DHA-only supplementation is sufficient. However, combined DHA+ARA formulations are better suited for several subgroups of adolescents:

• 1. Strict vegetarians who consume almost no meat or eggs and have minimal dietary ARA sources;
• 2. Individuals under sustained high mental strain, such as those preparing for major examinations, with elevated consumption in neural tissues;
• 3. Those with imbalanced dietary fat intake relying on limited types of vegetable oils, leading to compromised conversion efficiency of linoleic acid into ARA.

When adolescents take high-dose DHA-only supplements, DHA still competes with ARA for shared metabolic enzymes and may moderately reduce endogenous ARA synthesis efficiency. Though this competitive effect is less pronounced than in infants, long-term high-dose DHA-monotherapy carries risks of fatty-acid imbalance. Appropriately proportioned DHA+ARA products mitigate such metabolic competition, support nerve signal transmission and synaptic maturation, and benefit both cognitive performance and immune function. It should be noted that adolescents do not require infant-level high ARA doses. Formulations referencing the breast-milk-aligned ratio of 1:1 ~ 1:1.7 are preferred, and high-dose standalone ARA supplements are discouraged.

We now turn to older adults. Advancing age brings natural declines in metabolic-enzyme activity and reduced fatty-acid conversion capacity, alongside gradual brain degenerative changes. Nutritional priorities include preserving cognitive function, maintaining cell-membrane integrity, and balancing immune and inflammatory responses. Many senior-targeted nutritional products are fortified solely with DHA/EPA and contain little or no ARA. Meanwhile, a common market claim advises older adults to limit omega-6 intake to avoid inflammation.

Generally, healthy older adults with regular meals and adequate meat-and-egg intake should prioritise DHA and EPA supplementation without deliberate extra ARA fortification. Even so, combined DHA+ARA supplements offer greater value for certain senior subgroups:

• 1. Long-term vegetarians with very low meat-and-egg consumption and insufficient dietary ARA intake;
• 2. Frail, underweight individuals experiencing substantial muscle loss, given ARA's roles in cell-membrane repair and muscle-cell signal modulation;
• 3. Older adults whose erythrocyte-membrane ARA levels have declined following prolonged high-dose DHA-only supplementation; moderate ARA co-supplementation helps restore fatty-acid equilibrium.

The inflammation misconception must be reiterated here: ARA supplemented within physiological compliant doses does not directly induce chronic inflammation. For older populations, genuine concern should centre on overall dietary imbalance marked by excessive total omega-6 coupled with inadequate omega-3 intake, rather than modest proportional ARA within finished formulations. Individuals living with active autoimmune disorders or chronic inflammatory conditions should avoid high-ARA supplements and prioritise DHA/EPA-dominated products under medical supervision where necessary.

For consumers, straightforward actionable selection principles can be summarised:

• 1. Adolescents and older adults with balanced diets and sufficient meat-and-egg intake: choose DHA-containing (EPA-included) supplements; intentional ARA addition is unnecessary.
• 2. Vegetarians, people with minimal meat-and-egg intake, or those taking long-term high-dose standalone DHA: consider proportionally balanced DHA+ARA products to sustain fatty-acid homeostasis.
• 3. Both adolescents and older adults should avoid high-dose single-ingredient ARA supplements. Combination products should follow a 1:1 ~ 1:2 ratio; reject products where ARA far exceeds DHA.
• 4. Anyone with chronic inflammatory disease, autoimmune conditions or individuals taking anticoagulants should consult a clinical dietitian before commencing supplementation.

For purchasers and brand owners engaged in product development, clear product positioning is essential to prevent misleading marketing narratives:

• 1. Adolescent-targeted products: develop DHA+ARA complex formulations for niche groups including vegetarians and students under intense academic pressure. Meanwhile, maintain DHA-only variants for ordinary students with balanced diets. Marketing must not assert "ARA supplementation is mandatory for all adolescents"; messaging should emphasise "fatty-acid balance" instead of overstating ARA efficacy.
• 2. Senior-focused nutrition products: mainstream mass-market lines should remain DHA/EPA-based. DHA+ARA complex variants may be launched for niche segments such as frail older vegetarians, with clear labelling of intended users and precautionary statements for inflammation-prone populations.
• 3. Rigorous raw-material management: for complex formulations, keep ARA addition within physiological reference ranges and avoid indiscriminate over-fortification. Conduct consumer education to counter the online misconception equating ARA with inflammation, centring communication on "overall fatty-acid proportional balance" to mitigate regulatory-compliance risks.
• 4. Adhere to regulatory boundaries: China's dietary standards contain no official recommended daily ARA intake for adolescents or adults. Marketing communications must refrain from exaggerated disease-related or therapeutic claims.

In summary, the DHA+ARA "golden duo" is not exclusive to infants, nor is it compulsory for every adolescent or older adult. While infants require this combined pairing, well-nourished adolescents and older adults with adequate diets may prioritise DHA/EPA alone. Combined DHA+ARA supplements are more appropriate for vegetarians, those with insufficient dietary intake, and individuals on long-term high-dose DHA monotherapy. For both consumers and industry developers, product choices should not blindly favour complex blends. Instead, decisions ought to be guided by personal dietary patterns and physiological status to achieve overall long-chain polyunsaturated fatty-acid balance.

References

[1] Chinese Nutrition Society. Chinese Dietary Reference Intakes (2023 Edition) [M]. Beijing: People's Medical Publishing House, 2023.

[2] Yang Yuexin. Chinese Encyclopedia of Nutrition Science (2nd Edition) [M]. Beijing: People's Medical Publishing House, 2019.

[3] Yin Shian. Human Milk Composition: Forms, Contents, Functions and Detection Methods [M]. Beijing: Chemical Industry Press, 2016.

[4] Hadley K B, Ryan A S, Forsyth S, et al. The essentiality of arachidonic acid in infant development [J]. Nutrients, 2016, 8(4):216.

[5] Calder P C. A systematic review of the effects of increasing arachidonic acid intake on PUFA status, metabolism and health-related outcomes in humans [J]. British Journal of Nutrition, 2019, 121(10):1121-1134.

[6] Expert Group on DHA Supplementation for Chinese Pregnant, Lactating Women and Infants. Expert consensus on DHA supplementation for Chinese pregnant, lactating women and infants [J]. Chinese Journal of Reproductive Health, 2015, 26(2):101-105.

[7] Koletzko B, et al. Current information and Asian perspectives on long-chain polyunsaturated fatty acids in pregnancy, lactation, and infancy [J]. Annals of Nutrition and Metabolism, 2014, 65:49-80.

[8] Neuhauser-Berthold M. Arachidonic acid as a potentially critical nutrient for vegetarians and vegans-position paper [J]. Nutrients, 2025, 17(7):1432.